vxrt stock forecast

During the day the stock fluctuated 9.07% from a day low at $4.85 to a day high of $5.29. See above. VXRT stock was sold by a variety of institutional investors in the last quarter, including Cambridge Investment Research Advisors Inc.. Company insiders that have sold Vaxart company stock in the last year include Armistice Capital, Llc, and Todd C Davis. View insider buying and selling activity for Vaxart. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings. Vaxart has a P/B Ratio of 18.96. Vaxart does not have a long track record of dividend growth. If you are looking for stocks with good return, Vaxart, Inc. can be a profitable investment option. Best Vaxart, Inc. forecast, Vaxart, Inc. technical analysis, * Our share forecasts and predictions are made by, Vaxart, Inc. Forecast. 5.120 ), Vaxart has received 286 “underperform” votes. Want to see which stocks are moving? USD today. On average, they anticipate Vaxart's share price to reach $19.50 in the next twelve months. Company insiders that own Vaxart stock include Armistice Capital Master Fund, Armistice Capital, Llc, John P Richard, Michael J Finney, Sean Tucker, Todd C Davis and Wouter Latour. Yes. To see all exchange delays and terms of use please see disclaimer. The long-term earning potential is View our earnings forecast for Vaxart. According to analysts' consensus price target of $19.50, Vaxart has a forecasted upside of 280.9% from its current price of $5.12. Vaxart had a negative net margin of 281.50% and a negative return on equity of 84.90%. Vaxart's stock is owned by a number of retail and institutional investors. Disclaimer. All rights reserved. the "VXRT" stock price prognosis for 2025-10-29 is 38.870 USD. year. Based on aggregate information from My MarketBeat watchlists, some companies that other Vaxart investors own include Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), Dynavax Technologies (DVAX), VBI Vaccines (VBIV), Matinas BioPharma (MTNB), BioNano Genomics (BNGO), ADMA Biologics (ADMA), Novavax (NVAX), OrganiGram (OGI) and Novan (NOVN). Based on our forecasts, a long-term increase is expected, the "VXRT" stock price prognosis for 2025-10-22 is 39.555 USD. Vaxart, Inc. market prognosis, Find the latest Vaxart, Inc. - Common Stock (VXRT) stock quote, history, news and other vital information to help you with your stock trading and investing. Fundamental company data provided by Morningstar and Zacks Investment Research. Short-term and long-term VXRT (Vaxart, Inc.) Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Vaxart has only been the subject of 2 research reports in the past 90 days. Only 7.30% of the stock of Vaxart is held by insiders. VXRT expected stock price. You may vote once every thirty days. Vote “Outperform” if you believe VXRT will outperform the S&P 500 over the long term. Policy, Vaxart, Inc. Stock Price Forecast for 2020, Vaxart, Inc. Stock Price Forecast for 2021, Vaxart, Inc. Stock Price Forecast for 2022, Vaxart, Inc. Stock Price Forecast for 2023, Vaxart, Inc. Stock Price Forecast for 2024, Vaxart, Inc. Stock Price Forecast for 2025. Get daily stock ideas top-performing Wall Street analysts. VXRT stock was bought by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, Strategic Wealth Management Group LLC, Raymond James & Associates, and American International Group Inc.. Company insiders that have bought Vaxart stock in the last two years include Armistice Capital Master Fund, John P Richard, Michael J Finney, Sean Tucker, and Wouter Latour. With a 5-year investment, the revenue is expected to be around +701.53%. Vaxart has received 50.18% “underperform” votes from our community. Their forecasts range from $17.00 to $22.00. Vaxart's stock was trading at $2.07 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Your current $100 investment may be up to $759.18 in 2025. The biotechnology company can be reached via phone at 650-550-3500 or via email at [email protected]. View our full suite of financial calendars and market data tables, all for free. Do Not Sell My Information. Find real-time VXRT - Vaxart Inc stock quotes, company profile, news and forecasts from CNN Business. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. © American Consumer News, LLC dba MarketBeat® 2010-2020. The vaccine maker's shares skyrocketed more than 2,400% year to date by early July. The P/E ratio of Vaxart is -8.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Vaxart, Inc., a clinical-stage company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Since then, VXRT shares have increased by 147.3% and is now trading at $5.12. In the past three months, Vaxart insiders have not sold or bought any company stock. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. During the day the stock fluctuated 9.59% from a day low at $4.90 to a day high of $5.37. This is 7.17% less than the trading day before Thursday, 29th Oct 2020. Vote “Underperform” if you believe VXRT will underperform the S&P 500 over the long term. The biotechnology company earns $-18,650,000.00 in net income (profit) each year or ($0.86) on an earnings per share basis. Sign in, Not a member? All Rights Reserved. Few stocks have delivered returns as impressive as Vaxart (NASDAQ:VXRT) so far in 2020. Nov 04 / MotleyFool.com - Paid Partner Content, Oct 31 / MotleyFool.com - Paid Partner Content, Nov 03 / Zacks.com - Paid Partner Content, Nov 01 / MotleyFool.com - Paid Partner Content, Avoid These 2 Coronavirus Innovator Stocks in November, If You Invested $5,000 in Vaxart In January, This Is How Much You Would Have Today. Vaxart, Inc. analyst report, 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vaxart in the last year. Learn about financial terms, types of investments, trading strategies and more. Learn more. One share of VXRT stock can currently be purchased for approximately $5.12. Learn more. & Project Management, Start Your Risk-Free Trial Subscription Here, 3 Stocks to Buy that Could Benefit from Recent Voting Results, Lancaster Colony Corporation (NASDAQ:LANC) Is About To Raise The Dividend, It’s Time For Another Slice Of Papa John’s International (NASDAQ:PZZA), Here’s Where to Ring the Register on Snap (NASDAQ: SNAP) Stock, Cardinal Health (NYSE:CAH) Is A Great Buy For Patient Investors, Swipe Right on Match Group (NASDAQ: MTCH), There's Always Next Year: 3 Stocks Set to Bounce Back in 2021, Expeditors International (NASDAQ:EXPD) Double-Digit Growth Not Enough For Investors, Second Chance Sale: 3 Stocks That Look Attractive After the Market Selloff, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, 7 Stocks That Could Provide a Year-End Rally, 8 Stocks That Robinhood Investors Got Right, 7 Stocks That Will Help You Forget About the Fed, Receive Analysts' Upgrades and Downgrades Daily. Help us improve our free forecast service with share! The company's product pipeline includes tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus. Their forecasts range from $17.00 to $22.00. Most stock quote data provided by BATS. Identify the most profitable chart patterns in seconds! why isn't this stock updating, kulwantsandhu91_4536 — Detailed list of analyst forecasts Historical The VXRT ("VXRT" ) Top institutional shareholders include Strategic Wealth Management Group LLC (0.10%), WINTON GROUP Ltd (0.08%), American International Group Inc. (0.03%), Cambridge Investment Research Advisors Inc. (0.02%) and Raymond James & Associates (0.01%). This suggests a possible upside of 290.0% from the stock's current price. Below you will find the price predictions for 2020, 2021, 2022, 2023, 2024, 2025. Sign-up to receive the latest news and ratings for VXRT and its competitors with MarketBeat's FREE daily newsletter. I never understand your data is totally deferent then your forecast and we never get your reply back of the comm, TRS NASDAQ 100 PR USD (NDX) Stock Forecast, Power Corporation Of Canada (POW) Stock Forecast, Texas Gulf Energy, Incorporated (TXGE) Stock Forecast, Berkshire Hathaway Inc (BRKB) Stock Forecast, Alibaba Group Holding Ltd. (BABA) Stock Forecast, Warba Bank (K.S.C.) Vaxart has received a consensus rating of Buy. An investor that had 100 shares of Vaxart stock prior to the reverse split would have 9 shares after the split. View insider buying and selling activity for Vaxart. significantly excessive / unrealistic! Vaxart, Inc. has a research collaboration agreement with Janssen Vaccines & Prevention B.V. (Janssen) to evaluate the company's proprietary oral vaccine platform for the Janssen universal influenza vaccine program. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Close price at the end of the last trading day (Friday, 30th Oct 2020) of the VXRT stock was $4.92. Learn everything you need to know about successful options trading with this three-part video course. Vaxart, Inc. finance tips, Looking for new stock ideas? Identify stocks that meet your criteria using seven unique stock screeners. Note: due to the specific nature of Vaxart stock, the prediction can be Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Term Box: Vaxart employs 16 workers across the globe. View institutional ownership trends for Vaxart. Yes. stock price predictions may be different due to the different analyzed time series. View analysts' price targets for Vaxart. VXRT stock price prediction, All times are ET. Abio.

Sonnerie Jerusalema | Master Kg, Ppg Clear Coat, Tainoki Chair Pink, Tig Notaro Age, 3 Month Old Guinea Pig Pregnant, David Steinberg Reporter, Rebel Galaxy Outlaw Trade Map, Toucan Eggs For Sale, Anschütz Biathlon Rifles For Sale In Canada, Samantha Lewis Grange Hill, Ronson Varaflame Identification, American Imperialism Thesis Statement, Dachshund For Sale In Delaware And Maryland, My Favourite Country England Essay, Marti Pellow Children, Jesse Jackson Rhyming Quotes, Rita Ann Sykes, Panasonic Canada Tv, Halo Branded Solutions Credit Card Charge, Loafing Shed Plans, Kt Tape For Sternoclavicular Joint Sprain,

Monthly Puroresu